Lenvatinib N-Oxide
Lenvatinib N-Oxide is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Lenvatinib. The product is supplied by Clearsynth under CAT No. CS-O-32596. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Product Specifications
Overview
Lenvatinib N-Oxide is a metabolite of Lenvatinib which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
CAS Number
1788901-86-9
Synonyms
Lenvatinib N-Oxide
Molecular Formula
C 21 H 19 ClN 4 O 5
Molecular Weight
442.85
Additionnal Information
Lenvatinib N-Oxide is supplied with detailed characterization data compliant with regulatory guideline. Lenvatinib N-Oxide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Lenvatinib.
Storage Conditions
Refer MSDS for complete information.
Applications Notes
Lenvatinib N-Oxide is a metabolite of Lenvatinib which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
HSN Code
38229010
Hazard Compound
Refer MSDS for complete information.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
V9382-100UG 100 µg
Recombinant CFTR Antibody / Cystic Fibrosis Transmembrane Regulator
Sign In for Pricing
View Details 
MBS6358142-01 0.2 mL
TRIM11, CT (TRIM11, RNF92, E3 ubiquitin-protein ligase TRIM11, Protein BIA1, RING finger protein 92, Tripartite motif-containing protein 11) (PE)
Sign In for Pricing
View Details MBS6358142-02 5x 0.2 mL
TRIM11, CT (TRIM11, RNF92, E3 ubiquitin-protein ligase TRIM11, Protein BIA1, RING finger protein 92, Tripartite motif-containing protein 11) (PE)
Sign In for Pricing
View Details 
